These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
34 related articles for article (PubMed ID: 475352)
1. Spinal fluid aluminum levels in patients with Alzheimer disease. Delaney JF Ann Neurol; 1979 Jun; 5(6):580-1. PubMed ID: 475352 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-12 is reduced in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia. Rentzos M; Paraskevas GP; Kapaki E; Nikolaou C; Zoga M; Rombos A; Tsoutsou A; Vassilopoulos D D J Neurol Sci; 2006 Nov; 249(2):110-4. PubMed ID: 16843497 [TBL] [Abstract][Full Text] [Related]
3. IL-15 is elevated in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia. Rentzos M; Zoga M; Paraskevas GP; Kapaki E; Rombos A; Nikolaou C; Tsoutsou A; Vassilopoulos D J Geriatr Psychiatry Neurol; 2006 Jun; 19(2):114-7. PubMed ID: 16690997 [TBL] [Abstract][Full Text] [Related]
4. Elevated levels of neural recognition molecule L1 in the cerebrospinal fluid of patients with Alzheimer disease and other dementia syndromes. Strekalova H; Buhmann C; Kleene R; Eggers C; Saffell J; Hemperly J; Weiller C; Müller-Thomsen T; Schachner M Neurobiol Aging; 2006 Jan; 27(1):1-9. PubMed ID: 16298234 [TBL] [Abstract][Full Text] [Related]
5. Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study. Hampel H; Buerger K; Zinkowski R; Teipel SJ; Goernitz A; Andreasen N; Sjoegren M; DeBernardis J; Kerkman D; Ishiguro K; Ohno H; Vanmechelen E; Vanderstichele H; McCulloch C; Moller HJ; Davies P; Blennow K Arch Gen Psychiatry; 2004 Jan; 61(1):95-102. PubMed ID: 14706948 [TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease. Grossman M; Farmer J; Leight S; Work M; Moore P; Van Deerlin V; Pratico D; Clark CM; Coslett HB; Chatterjee A; Gee J; Trojanowski JQ; Lee VM Ann Neurol; 2005 May; 57(5):721-9. PubMed ID: 15852395 [TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses? Clark CM; Xie S; Chittams J; Ewbank D; Peskind E; Galasko D; Morris JC; McKeel DW; Farlow M; Weitlauf SL; Quinn J; Kaye J; Knopman D; Arai H; Doody RS; DeCarli C; Leight S; Lee VM; Trojanowski JQ Arch Neurol; 2003 Dec; 60(12):1696-702. PubMed ID: 14676043 [TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid acetylcholine, choline, and senile dementia of the Alzheimer's type. Davis KL; Hsieh JY; Levy MI; Horvath TB; Davis BM; Mohs RC Psychopharmacol Bull; 1982 Oct; 18(4):193-5. PubMed ID: 7156289 [No Abstract] [Full Text] [Related]
9. Alpha 1-antichymotrypsin as a possible biochemical marker for Alzheimer-type dementia. Matsubara E; Hirai S; Amari M; Shoji M; Yamaguchi H; Okamoto K; Ishiguro K; Harigaya Y; Wakabayashi K Ann Neurol; 1990 Oct; 28(4):561-7. PubMed ID: 2147546 [TBL] [Abstract][Full Text] [Related]
10. Increased levels of neuronal thread protein in cerebrospinal fluid of patients with Alzheimer's disease. de la Monte SM; Volicer L; Hauser SL; Wands JR Ann Neurol; 1992 Dec; 32(6):733-42. PubMed ID: 1471863 [TBL] [Abstract][Full Text] [Related]
11. Low serum potassium in mid life associated with decreased cerebrospinal fluid Abeta42 in late life. Mielke MM; Zandi PP; Blennow K; Gustafson D; Sjögren M; Rosengren L; Skoog I Alzheimer Dis Assoc Disord; 2006; 20(1):30-6. PubMed ID: 16493233 [TBL] [Abstract][Full Text] [Related]
12. [Interest of CSF beta-amyloid1-42 and t-tau protein level determinations for the diagnosis of Alzheimer's disease]. Smach MA; Charfeddine B; Lammouchi T; Dridi H; Ben Othman L; Bennamou S; Limem K Ann Biol Clin (Paris); 2008; 66(5):531-5. PubMed ID: 18957342 [TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies. Parnetti L; Tiraboschi P; Lanari A; Peducci M; Padiglioni C; D'Amore C; Pierguidi L; Tambasco N; Rossi A; Calabresi P Biol Psychiatry; 2008 Nov; 64(10):850-5. PubMed ID: 18395699 [TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Tapiola T; Alafuzoff I; Herukka SK; Parkkinen L; Hartikainen P; Soininen H; Pirttilä T Arch Neurol; 2009 Mar; 66(3):382-9. PubMed ID: 19273758 [TBL] [Abstract][Full Text] [Related]